Difference between revisions of "Nagata T, et al. Breast Cancer (2014) cited as Ref 87 in DOI: 10.1038/s41392-020-0110-5 (Q9350)"
Jump to navigation
Jump to search
(Created claim: PubMed ID (P140): 22528804, #quickstatements; #temporary_batch_1590001671040) |
(Created claim: Page(s) (P105): 96-101, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (4 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2014
| ||||||||||||||
| Property / Publication Date: 2014 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Breast Cancer | ||||||||||||||
| Property / Published In Name String: Breast Cancer / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 21 | ||||||||||||||
| Property / Volume: 21 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Prognostic significance of NANOG and KLF4 for breast cancer (English) | ||||||||||||||
| Property / title: Prognostic significance of NANOG and KLF4 for breast cancer (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 96-101 | ||||||||||||||
| Property / Page(s): 96-101 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:30, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Nagata T, et al. Breast Cancer (2014) cited as Ref 87 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Nagata T
0 references
2014
0 references
Breast Cancer
0 references
21
0 references
Prognostic significance of NANOG and KLF4 for breast cancer (English)
0 references
96-101
0 references
